Reversal learning and associated retention probes
Animal study · Male Wistar rats; biperiden n = 10, control n = 12 at design entry. [1]
Reversal learning showed no main treatment effect. In the final probe, the treated group spent less time in the target quadrant than controls. Solvent matching is unclear from the reported formulations.
| Endpoint | Reported result | Reference |
|---|---|---|
| Escape latency: main effect of biperiden administration | Reported group comparison t(19.9) = −0.49; p = 0.63; b = −1.37; 95% CI [−6.79, 4.05] | [1] |
| Final reversal-day target-quadrant time | Reported group comparison M_biperiden = 22.05 s; M_control = 30.87 s; t(19) = −2.97; p = 0.008; d = −1.27; 95% CI [−2.19, −0.33] | [1] |
Conditions shared by the study groups
- Route
- Subcutaneous
- Frequency
- Before the daily testing session
- Vehicle
- DMSO/saline. Drug: 100 μL DMSO per 1 mg BIP, diluted to 3 mg/mL. Control: 300 μL DMSO per 1 mL saline, as written.
| Group / dose | Comparator | Observed result | Reference |
|---|---|---|---|
| Biperiden 3 mg/kg | Reported DMSO/saline control | Final probe target-quadrant mean 22.05 s; reversal learning main treatment effect nonsignificant. | [1] |
| Vehicle control Vehicle only | Comparator for biperiden arm | Final probe target-quadrant mean 30.87 s. | [1] |
- Biperiden
- Model: Male Wistar rats, n = 10
- Treatment course: Days 4–5 of a five-day task
- Reported limits: Enantiomeric composition and unambiguous matching of final solvent proportions are not established.
- Vehicle control
- Model: Male Wistar rats, n = 12
- Treatment course: Five-day task; drug treatment comparison on days 4–5
- Reported limits: Enantiomeric composition and unambiguous matching of final solvent proportions are not established.
Methods and source locations
Compound reported in the paper: Biperiden hydrochloride; Compound label in the paper: BIP
Published hydrochloride experiment; no Adooq lot validation or equivalence of stereochemical composition is established.
PDF p.3, Experimental procedures: Animals and Drugs; Reversal design pp.3–4; statistical analysis p.5; Results p.6; Figs.4a and 5a, pp.7–8
Escape latency: main effect of biperiden administration: Mixed-effect regression; numbers transcribed from Results, not estimated from plots. — PDF p.6, Results: Reversal; Fig.4a on p.7
Final reversal-day target-quadrant time: Mixed-effect regression; numbers transcribed from Results, not estimated from plots. — PDF p.6, Results: Probe trials—reversal; Fig.5a on p.8
Biperiden · PDF p.3, Experimental procedures: Animals and Drugs; Reversal design on pp.3–4; Results p.6; Figs.4a,5a
Vehicle control · PDF p.3, Experimental procedures: Animals and Drugs; Reversal design on pp.3–4; Results p.6; Fig.5a